Clinerion Expands RWD Platform to Offer Unique Healthcare Insights Using EHR Data

Clinerion's RWD RADAR provides daily updated, aggregate analytics on patient groups and the patient journey across the Patient Network Explorer hospital network. 

FREMONT, CA : Across the Patient Network Explorer hospital network, Clinerion's RWD RADAR provides daily updated, aggregate analytics on patient groups and the patient journey, such as the usage of terminologies, covering diagnosis, diagnosis, laboratory tests, and procedures.

RWD RADAR produces patient cohort aggregate metrics and provides metrics on the patient journey, from diagnosis to treatment modalities, and regionally, all dependent on real-world data available on Clinerion's Patient Network Explorer platform, which supports epidemiological research. Patient cohort aggregate metrics are visualized as Top N lists, ranking the relevant terms inside a field code with the highest patient hits and provide insight into disease-treatment and disease-disease correlations.

The statistics depend on real-time data and include timestamps, enabling an incidence timeline to be constructed. In addition, data can be aggregated or regionally mapped, and gender and age distributions can be displayed.

With a footprint in 25 countries worldwide, Clinerion's Patient Network Explorer is unique in the environment of EHR-based real-world data solutions, providing a combination of multi-dimensional query definition, real-time search across multiple networked electronic health record systems made interoperable through the use of semantic and ontology methods, and a highly scalable hybrid cloud and federated-local-installation-based platform.

"The metrics and statistics offered under RWD RADAR provide a great insight into the power and value of the data accessible by Patient Network Explorer," says Andreas Walter, Clinerion CTO. "The new statistical tools give users access to more fine detail to understand disease progression and diagnosis, as well as gain insights on treatment regimens and outcomes. Our new federated machine learning framework will develop and derive more insights from our patient data pools."

"RWD RADAR is just the first development in the evolution of Patient Network Explorer, as Clinerion capitalizes on the promise of tangible, actionable, valuable real-world insights, derivable from the real-world data on our platform," says Baris Erdogan, Clinerion CEO. "We continue to develop the capabilities and functionalities of the platform to offer maximum support to our clients in obtaining the full benefit of Clinerion's hospital network."